Eli Lilly and Company

NYSE:LLY Stock Report

Market Cap: US$967.3b

Eli Lilly Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NYSE:LLY Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
29 Dec 25SellUS$3,898,531Lilly Endowment, Inc, Endowment ArmCompany3,593US$1,085.04
24 Dec 25SellUS$3,113,329Lilly Endowment, Inc, Endowment ArmCompany2,869US$1,085.17
25 Nov 25SellUS$178,423,264Lilly Endowment, Inc, Endowment ArmCompany162,693US$1,110.53
24 Nov 25SellUS$152,058,091Lilly Endowment, Inc, Endowment ArmCompany142,307US$1,073.60
21 Nov 25SellUS$111,504,098Lilly Endowment, Inc, Endowment ArmCompany105,326US$1,066.15
20 Nov 25SellUS$39,067,117Lilly Endowment, Inc, Endowment ArmCompany37,148US$1,055.39
19 Nov 25SellUS$176,098,702Lilly Endowment, Inc, Endowment ArmCompany167,526US$1,055.08
18 Nov 25SellUS$62,306,969Lilly Endowment, Inc, Endowment ArmCompany60,213US$1,039.61
17 Nov 25SellUS$10,189,269Lilly Endowment, Inc, Endowment ArmCompany9,886US$1,031.53
14 Nov 25SellUS$183,799,044Lilly Endowment, Inc, Endowment ArmCompany178,295US$1,033.16
13 Nov 25SellUS$48,016,098Lilly Endowment, Inc, Endowment ArmCompany46,606US$1,031.78
12 Nov 25SellUS$308,411,204Lilly Endowment, Inc, Endowment ArmCompany305,000US$1,021.07
11 Nov 25SellUS$295,753,076Lilly Endowment, Inc, Endowment ArmCompany300,000US$999.09
05 Nov 25SellUS$205,565,546Lilly Endowment, Inc, Endowment ArmCompany219,474US$954.95
04 Nov 25SellUS$479,038Lilly Endowment, Inc, Endowment ArmCompany526US$910.72
03 Nov 25SellUS$266,648,921Lilly Endowment, Inc, Endowment ArmCompany300,000US$900.79
31 Oct 25SellUS$260,165,031Lilly Endowment, Inc, Endowment ArmCompany301,342US$869.47
10 Oct 25SellUS$3,157,722Lilly Endowment, Inc, Endowment ArmCompany3,658US$863.37
09 Oct 25SellUS$9,038,055Lilly Endowment, Inc, Endowment ArmCompany10,602US$857.26
08 Oct 25SellUS$86,234,874Lilly Endowment, Inc, Endowment ArmCompany101,420US$856.00
07 Oct 25SellUS$22,722,401Lilly Endowment, Inc, Endowment ArmCompany26,795US$848.01
06 Oct 25SellUS$137,041,657Lilly Endowment, Inc, Endowment ArmCompany161,183US$855.71
03 Oct 25SellUS$161,220,401Lilly Endowment, Inc, Endowment ArmCompany192,404US$847.60
02 Oct 25SellUS$92,503,361Lilly Endowment, Inc, Endowment ArmCompany112,596US$833.92
01 Oct 25SellUS$284,653,465Lilly Endowment, Inc, Endowment ArmCompany351,015US$833.15
30 Sep 25SellUS$86,793,274Lilly Endowment, Inc, Endowment ArmCompany113,694US$766.12
19 Sep 25SellUS$18,058,643Lilly Endowment, Inc, Endowment ArmCompany23,665US$764.47
18 Sep 25SellUS$81,531,959Lilly Endowment, Inc, Endowment ArmCompany106,626US$767.07
15 Aug 25BuyUS$494,627Lucas MontarceIndividual715US$691.79
13 Aug 25BuyUS$647,360Jacob Van NaardenIndividual1,000US$647.36
13 Aug 25BuyUS$500,473Ralph AlvarezIndividual758US$660.25
12 Aug 25BuyUS$634,405Daniel SkovronskyIndividual1,000US$634.41
12 Aug 25BuyUS$1,005,242Jon Erik FyrwaldIndividual1,565US$642.59
12 Aug 25BuyUS$1,052,263David RicksIndividual1,632US$644.77
12 Aug 25BuyUS$75,018Gaby SulzbergerIndividual117US$641.18
08 Aug 25BuyUS$127,913Jamere JacksonIndividual200US$639.56
24 Jul 25SellUS$225,419,259Lilly Endowment, Inc, Endowment ArmCompany280,000US$808.34
03 Mar 25SellUS$204,326,151Lilly Endowment, Inc, Endowment ArmCompany220,000US$934.89
25 Feb 25SellUS$203,190,794Lilly Endowment, Inc, Endowment ArmCompany225,000US$911.55
24 Feb 25SellUS$53,419,955Lilly Endowment, Inc, Endowment ArmCompany60,432US$891.87
21 Feb 25SellUS$87,786,505Lilly Endowment, Inc, Endowment ArmCompany99,452US$893.75
20 Feb 25SellUS$12,893,353Lilly Endowment, Inc, Endowment ArmCompany14,685US$880.14
19 Feb 25SellUS$8,771,285Lilly Endowment, Inc, Endowment ArmCompany9,985US$880.44
13 Feb 25SellUS$31,175,396Lilly Endowment, Inc, Endowment ArmCompany35,446US$883.45
06 Feb 25SellUS$183,567,262Lilly Endowment, Inc, Endowment ArmCompany210,000US$887.32

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of LLY?
Owner TypeNumber of SharesOwnership Percentage
Private Companies5090.0000568%
State or Government880,5700.0983%
Individual Insiders1,373,5120.153%
General Public115,290,87212.9%
Institutions777,835,08986.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 62.34% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10.3%
Lilly Endowment Inc.
92,190,516US$99.6b-3.46%100.0%
9.04%
The Vanguard Group, Inc.
80,959,089US$87.5b0.69%1.03%
7.34%
BlackRock, Inc.
65,695,109US$71.0b-0.22%0.92%
5.71%
The PNC Financial Services Group, Inc.
51,147,503US$55.3b0.14%33.17%
5.64%
Capital Research and Management Company
50,494,500US$54.6b4.55%2.15%
3.88%
State Street Global Advisors, Inc.
34,726,558US$37.5b0.64%1.15%
2.47%
FMR LLC
22,115,370US$23.9b-6.05%1.19%
2.21%
Geode Capital Management, LLC
19,817,887US$21.4b9.32%1.15%
1.63%
T. Rowe Price Group, Inc.
14,573,132US$15.7b-18.3%1.27%
1.63%
Wellington Management Group LLP
14,563,780US$15.7b4.1%2.36%
1.39%
State Farm Mutual Automobile Insurance Company
12,480,217US$13.5b-0.27%10.11%
1.26%
Norges Bank Investment Management
11,324,406US$12.2b0%0.8%
1.21%
PRIMECAP Management Company
10,795,338US$11.7b-11.2%7.71%
1.16%
UBS Asset Management AG
10,403,202US$11.2b-11.8%0.84%
1.02%
Morgan Stanley
9,120,810US$9.9b2.7%0.91%
0.99%
Northern Trust Global Investments
8,899,035US$9.6b-1.22%1.16%
0.69%
JP Morgan Asset Management
6,133,626US$6.6b-23.7%0.59%
0.65%
Eaton Vance Management
5,838,895US$6.3b1.62%1.19%
0.63%
Charles Schwab Investment Management, Inc.
5,633,643US$6.1b5.1%0.81%
0.61%
Goldman Sachs Asset Management, L.P.
5,455,558US$5.9b12.9%1.16%
0.61%
Managed Account Advisors LLC
5,425,920US$5.9b-0.79%0.89%
0.6%
Legal & General Investment Management Limited
5,383,999US$5.8b2.96%1.07%
0.59%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
5,275,212US$5.7b-4.83%1.12%
0.55%
BNY Asset Management
4,900,125US$5.3b-2.31%0.91%
0.54%
AllianceBernstein L.P.
4,809,983US$5.2b-7.75%1.45%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/01/04 01:49
End of Day Share Price 2026/01/02 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Eli Lilly and Company is covered by 53 analysts. 29 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David ToungArgus Research Company
Kerry HolfordBerenberg
Luisa HectorBerenberg